---
figid: PMC6142582__bloodbook-2017-298-g002
figtitle: Targetable molecular features of primary mediastinal large B-cell lymphoma
  and mediastinal gray zone lymphoma
organisms:
- NA
pmcid: PMC6142582
filename: bloodbook-2017-298-g002.jpg
figlink: /pmc/articles/PMC6142582/figure/F2/
number: F2
caption: Targetable molecular features of primary mediastinal large B-cell lymphoma
  and mediastinal gray zone lymphoma. (A) The main activation cascades of JAK-STAT
  and NF-κB signaling are shown leading to altered transcriptional regulation. Only
  representative pathway molecules are displayed. Known gene alterations in the pathway
  are highlighted in color, and pathway inhibitors are shown in the red boxes. (B)
  A selection of surface markers as part of a PMBCL-specific expression profile is
  depicted alongside targeted therapeutic approaches. (C) Structural genomic alterations
  of chromosome 9p24 lead to overexpression of programmed death ligands that are potentially
  amenable to immunological checkpoint inhibition. Dunleavy and Steidl.
papertitle: 'Primary mediastinal B-cell lymphoma: biology and evolving therapeutic
  strategies.'
reftext: Kieron Dunleavy. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):298-303.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6811055
figid_alias: PMC6142582__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6142582__F2
ndex: c2de8346-df33-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6142582__bloodbook-2017-298-g002.html
  '@type': Dataset
  description: Targetable molecular features of primary mediastinal large B-cell lymphoma
    and mediastinal gray zone lymphoma. (A) The main activation cascades of JAK-STAT
    and NF-κB signaling are shown leading to altered transcriptional regulation. Only
    representative pathway molecules are displayed. Known gene alterations in the
    pathway are highlighted in color, and pathway inhibitors are shown in the red
    boxes. (B) A selection of surface markers as part of a PMBCL-specific expression
    profile is depicted alongside targeted therapeutic approaches. (C) Structural
    genomic alterations of chromosome 9p24 lead to overexpression of programmed death
    ligands that are potentially amenable to immunological checkpoint inhibition.
    Dunleavy and Steidl.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - TNFAIP3
  - IGKV1-27
  - AGFG1
  - RIPK1
  - DCAF1
  - RPAIN
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - SOCS1
  - PTPN1
  - IKBKG
  - CHUK
  - IKBKB
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - REL
  - NFKB1
  - RELA
  - RELB
  - NFKB2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - CASR
  - CXADR
  - PRKAR1A
  - SPG7
  - NR1I3
  - TRIM13
  - CXADRP1
  - PDCD1LG2
  - MS4A1
  - KRT20
  - CD19
  - TNFRSF8
  - Juvenile rheumatoid arthritis
  - Rheumatoid arthritis
---
